Private company · employee equity guide

PPrecision Neuroscience logo

What is Precision Neuroscience stock worth?

Precision Neuroscience is pioneering a brain implant, known as a brain-computer interface (BCI), to restore communication and independence for people with neurological conditions. Our cutting-edge technology is designed to empower people with paralysis to control digital devices—such as computers and smartphones—with their thoughts alone, opening new possibilities for daily life. Precision’s multidisciplinary team brings together leading experts in diverse fields such as neurosurgery, artificial intelligence, machine learning, microfabrication, electrical engineering, and more. We are committ

Estimated share price

Members onlySee the real chart, freeNo card. Takes about a minute.

Precision Neuroscience has an observed estimated price: most recent data 2026-09-15, daily history back to 2024-11-10.

Estimated from live trades and accepted bids across employer liquidity programs, institutional trades, broker trades, and pre-IPO marketplaces. Private shares are illiquid and transfer-restricted; estimates are educational, not an offer or advice. The preview above is blurred and illustrative. How this is calculated

About Precision Neuroscience

Employees
124
Founded
2021
Industry
Medical Equipment Manufacturing, Manufacturing
Website
precisionneuro.io

Weighing a Precision Neuroscience offer?

Upload the offer letter to see what the equity is approximately worth at today's estimated price. No account needed.

X-ray an offer

Leaving Precision Neuroscience? Mind the window.

If you hold options, leaving usually starts a post-termination exercise clock, often 90 days. Miss it and vested options can expire worthless; exercise blindly and you may owe real money (including possible AMT) on shares you can't yet sell. Neither panic nor autopilot is a plan. Knowing your window, your exercise cost, and the current estimated price is.

Track my window freeUpload your grant doc. We extract the window and set the reminders.

Who founded Precision Neuroscience

Benjamin Rapoport, Michael Mager

Precision Neuroscience news timeline

Precision Neuroscience equity, answered plainly

Is Precision Neuroscience a public company?

No. Precision Neuroscience is privately held, which is exactly why its share price doesn't show up in your brokerage app. The company (founded in 2021, operating in medical equipment manufacturing, with roughly 124 employees) remains private even at that scale. Its shares still change hands between eligible buyers and sellers on the secondary market, producing an observable estimated price.

What is Precision Neuroscience's stock price?

Precision Neuroscience has an observed estimated share price from secondary-market activity, updated as new data is observed. Its observed price history runs back to 2024-11-10. ExitCue members see the current estimate and its full history free, along with what their own grants are approximately worth at that price.

Can you sell Precision Neuroscience stock before an IPO?

Sometimes. Private-share sales depend on Precision Neuroscience's transfer restrictions, rights of first refusal, and whether the company runs tender offers or permits secondary sales. Your grant documents and the company's policies govern, but "hard to sell today" is not the same as "worth zero."

What happens to my Precision Neuroscience options if I leave?

Most option grants have a post-termination exercise window, commonly 90 days, sometimes longer, after which unexercised options expire worthless. The exact terms are in your grant documents. ExitCue reads those documents, tracks the deadline, and reminds you before the window closes.

How much is my Precision Neuroscience equity worth?

Multiply what you hold by the estimated share price, separating vested from unvested, and netting out strike prices for options. That's precisely the arithmetic ExitCue does for you, continuously, at the current observed estimate. It's an educational estimate, not a guarantee, and a far better anchor than the $0 the internet suggests.

What's the difference between Precision Neuroscience's 409A valuation and what its shares trade at?

The 409A is a tax-compliance appraisal, usually conservative, used to set option strike prices. Secondary-market pricing reflects what buyers and sellers actually agree to. The two frequently differ, which is why evaluating an offer on the 409A alone undersells (or oversells) it.

When will Precision Neuroscience IPO?

Unless Precision Neuroscience has publicly announced a listing, nobody knows, including the people who sound confident on forums. The practical upside of secondary markets is that you don't have to wait for an IPO to know approximately what the shares trade at.

Do my unvested Precision Neuroscience RSUs count for anything?

Unvested equity isn't yours yet, but it has an estimable value and a schedule. Seeing vested and unvested value separately, in dollars at the current estimated price, turns "some RSUs" into a number you can plan around.

General educational information, not advice about your specific situation. Grant terms vary; your documents govern.

Work out what your Precision Neuroscience equity is worth

These calculators take your own numbers and need no account.

New to this? Learn explains grant types, vesting and cliffs, and where an estimated share price comes from — in plain language.

Other private companies with observed prices

Company logos provided by Brandfetch.